RxDoctor Payments Data

Youl Kim, MD

Physical Medicine & Rehabilitation · Douglasville, GANPI 1003258674

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 37.2% of the total.

$1,764in general payments, 2019–2025

Across 111 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$656
  • Scilex Pharmaceuticals Inc.$327
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$255
  • Hikma Pharmaceuticals USA$122
  • Biodelivery Sciences International, Inc.$98
  • Almatica Pharma LLC$86
  • plus $219 from 7 others

What the payments were for

  • Food & beverage$1,764100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,764 in reported general payments places this provider in the 75th percentile of 214 physical medicine & rehabilitation providers in Georgia.

See all physical medicine & rehabilitation providers in Georgia

Medicare billing

Part B allowed, 2024
$220,897
Medicare patients
234
Services billed
2,461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,780$70,270
Xtampza ErOxycodone Myristate127$64,795
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen2,128$60,451
Nucynta ErTapentadol Hcl46$46,545
Buprenorphine79$23,086
RoxybondOxycodone Hcl12$22,402
Oxycodone Hcl839$17,613
OxycontinOxycodone Hcl26$14,828
Morphine Sulfate ErMorphine Sulfate481$14,195
BelbucaBuprenorphine Hcl17$12,877
MovantikNaloxegol Oxalate16$11,337
LinzessLinaclotide20$10,409
Lidocaine53$8,920
Fentanyl56$5,181
Morphine Sulfate111$3,666

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Belbuca$656$124,217190 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$122$26,752190 claims
Protega Pharmaceutials IncRoxybond$64$22,40212 claims
Redhill Biopharma Inc.Movantik$14$11,33716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 214 physical medicine & rehabilitation providers in Georgia.

Other physical medicine & rehabilitation in Douglasville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →